Device Trial Radar · NCT00094536
Evaluation of Modified Treatment Regimens for Treatment of Heavy Menstrual Bleeding Using the HerOption® System
Last checked: Nov 20, 2026Latest source record: Mar 3, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Sponsor
- Lead sponsor
- CooperSurgical Inc.Not on our public-company list
- Sponsor type
- Industry
- First posted
- Oct 21, 2004
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Other
- Who can join
- Female only, from 30 years, up to 100 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The Her Option® Cryoablation Therapy System is a closed-loop cryosurgical device that is used to ablate the endometrial lining in pre-menopausal women with menorrhagia (excessive menstrual bleeding) due to benign causes. This is a non-incisional procedure, which can be performed in a physicians office with minimal sedation. Initial FDA clinical studies were conducted with a two-freeze treatment pattern consisting of a 4 minute freeze with the Cryoprobe positioned in one cornu followed by a second freeze of 6 minutes with the Cryoprobe repositioned in the contralateral cornu. Since completion of the early studies, many physicians have experimented with varying freeze patterns using longer freeze durations and/or additional freezes at the fundus and the lower uterine segment. The results, as reported in the literature, indicate that these extended freeze patterns produce significantly better results than the original regimen.
Conditions
- Menorrhagia
Interventions
Extended treatment regimen using Her Option CryotherapyDevice
Extended treatment regimens using the Her Option Endometrial Cryotherapy System to more effectively ablate the endometrial lining, reducing menstrual levels to normal or less.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Success (Reduction in Menstruation to Normal Levels)Time frame: 1 Year
Locations
7 sites in 1 country. Site status is shown where the registry gives one.
Kelly Roy, M.D., P.C.
Phoenix, Arizona
6 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.